ABSI is trading at $10.76 (-5.03%) as the stock gives back recent gains while biotech shares weaken amid broader risk-off market sentiment.
- No fresh company-specific catalysts have been identified to explain today's downward move.
- The decline follows a period of strength supported by a recent insider purchase, with shares now tracking lower alongside major indices.
- The price action appears driven by sector-wide pressure rather than fundamental changes to the company.